A panel of experts review the evolving treatment landscape of biliary tract cancers contextualized with their real-world experiences.
February 15th 2023
Expert panelists open their discussion on biliary tract cancers by identifying various subsets and noting the growing incidence of these diseases.
Centering focus on a patient scenario, panelists break down mainstay diagnostic strategies used to identify biliary tract cancers.
February 22nd 2023
Focused conversation on the optimal workup and staging of biliary tract cancers within the current paradigm.
Key opinion leaders review the advent of molecular testing in biliary tract cancers and consider its impact on informing treatment decisionmaking.
March 1st 2023
Moving on to identify specific treatment modalities, panelists discuss the surgical and perioperative strategies used to manage biliary tract cancers.
A comprehensive review of liver-directed therapies available to aid in the management of biliary tract cancers.
March 8th 2023
A brief discussion on the continued role of liver transplant in biliary tract cancers and when it is appropriate to consider a patient for this procedure.
Key opinion leaders in the field of biliary tract cancers highlight mainstay systemic therapy regimens within the treatment paradigm.
March 15th 2023
Centering discussion on the TOPAZ-1 trial of chemotherapy in combination with durvalumab, panelists consider how this regimen has impacted clinical practice.
An overview on novel treatment strategies in biliary tract cancers combining immune checkpoint inhibitors with various targeted agents.
March 22nd 2023
Comprehensive insight on novel targeted agents under investigation in the setting of biliary tract cancers.
Closing out their discussion on biliary tract cancers, expert panelists share key takeaways and excitement for the evolving treatment paradigm.